Current Status and Perspectives of Tyrosine Kinase Inhibitor Treatment in the Posttransplant Period in Patients with Chronic Myelogenous Leukemia (CML)-Reference-Cited by-同舟云学术

Current Status and Perspectives of Tyrosine Kinase Inhibitor Treatment in the Posttransplant Period in Patients with Chronic Myelogenous Leukemia (CML)

Published:2010-03 Issue:3 Volume:16 Page:301-310
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Klyuchnikov Evgeny,Kröger Nicolaus,Brummendorf Tim H.,Wiedemann Bettina,Zander Axel Rolf,Bacher Ulrike

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference65 articles.

1. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001

2. Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis;Gambacorti-Passerini;Blood Cells Mol Dis,1997

3. In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor;Le Coutre;J Natl Cancer Inst,1999

4. Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure;Jabbour;Blood,2006

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group;British Journal of Haematology;2024-05-27

2. Prophylactic donor lymphocyte infusion for relapse prevention: a meta-analysis;Japanese Journal of Clinical Oncology;2020-02-24

3. Prevention and Treatment of Relapse After HLA-Haploidentical Hematopoietic Cell Transplantation;Haploidentical Transplantation;2017-11-06

4. Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options;American Journal of Case Reports;2017-10-16

5. Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program;Biology of Blood and Marrow Transplantation;2017-06